Juan Jesús
Cruz Hernández
Profesor Emérito
Hospital Miguel Servet
Zaragoza, EspañaPublicaciones en colaboración con investigadores/as de Hospital Miguel Servet (24)
2022
2021
-
Correction to: SEOM clinical guidelines for the treatment of head and neck cancer (2020) (Clinical and Translational Oncology, (2021), 23, 5, (913-921), 10.1007/s12094-020-02533-1)
Clinical and Translational Oncology
-
Implementation of the Quality Oncology Practice Initiative Program in Spain: First Results and Implications
JCO oncology practice, Vol. 17, Núm. 8, pp. e1162-e1169
-
Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial
Clinical and Translational Oncology, Vol. 23, Núm. 4, pp. 764-772
2019
-
Working towards a consensus on the oncological approach of breakthrough pain: A Delphi survey of Spanish experts
Journal of Pain Research, Vol. 12, pp. 2349-2358
2018
-
Clinical practice evaluation of opioids induced constipation management in oncologic patients: The EIO-50 project
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii612
-
Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice
Clinical and Translational Oncology, Vol. 20, Núm. 7, pp. 862-869
-
Oncologist’s knowledge and implementation of guidelines for breakthrough cancer pain in Spain: CONOCE study
Clinical and Translational Oncology, Vol. 20, Núm. 5, pp. 613-618
-
The quality oncology practice initiative program: Experience in Spain
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii570-viii571
2017
-
Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study
International Journal of Radiation Oncology Biology Physics, Vol. 97, Núm. 3, pp. 473-480
-
GEIS-21: A multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: A report from the Spanish sarcoma group (GEIS)
British Journal of Cancer, Vol. 117, Núm. 6, pp. 767-774
-
Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: A multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)
Annals of Oncology, Vol. 28, Núm. 12, pp. 2994-2999
2016
-
A nomogram for predicting complications in patients with solid tumours and seemingly stable febrile neutropenia
British Journal of Cancer, Vol. 114, Núm. 11, pp. 1191-1198
-
Epidemiological characteristics of a Spanish cohort of patients diagnosed with squamous cell carcinoma of head and neck: distribution of risk factors by tumor location
Clinical and Translational Oncology, Vol. 18, Núm. 11, pp. 1114-1122
-
Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study
Oral Oncology, Vol. 62, pp. 54-59
-
Quality indicators to assure and improve cancer care in Spain using the delphi technique
JNCCN Journal of the National Comprehensive Cancer Network, Vol. 14, Núm. 5, pp. 553-558
2014
-
A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer
Annals of Oncology, Vol. 25, Núm. 1, pp. 216-225
-
Análisis de impacto presupuestario del uso de fentanilo intranasal en pectina para el tratamiento del dolor irruptivo oncológico
Pharmacoeconomics - Spanish Research Articles, Vol. 11, Núm. 2, pp. 51-60
-
Social value of a quality-adjusted life year (QALY) in Spain: the point of view of oncologists
Clinical and Translational Oncology, Vol. 16, Núm. 10, pp. 914-920
2013
-
Optimal management of breakthrough cancer pain (BCP)
Clinical and Translational Oncology, Vol. 15, Núm. 7, pp. 526-534